EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Oophorectomy or ovarian conservation at the time of hysterectomy for benign disease

Victoria Asfour, Adam D Jakes, Jess McMicking, Wei Zian Szetho, Ahmad Sayasneh, Yasser Diab, Lawrence Mascarenhas, Janice Rymer

The Obstetrician & Gynaecologist · 2022-04 · 24 (2) · 131-136

DOI: 10.1111/tog.12799 ↗
AbstractBibliografische Angaben

Abstract

Key content Bilateral salpingo‐oophorectomy is indicated for patients with suspected or confirmed gynaecological malignancy. Risk reduction surgery is indicated in patients with a significant family history or a genetic predisposition to developing breast or ovarian cancer. Bilateral salpingectomy with ovarian conservation reduces the risk of ovarian cancer, whilst preserving ovarian function. Oophorectomy prior to the menopause is associated with increased all‐cause mortality and significant menopause related morbidity. Conservative measures such as weight loss, family planning and lifestyle advice could reduce the overall lifetime risk of ovarian cancer. Learning objectives To understand the rationale of the decision‐making process for bilateral salpingo‐oophorectomy or bilateral salpingectomy with ovarian conversation at the time of hysterectomy for benign disease. To understand the risk–benefit balance of performing oophorectomy in the context of risk reduction of high‐risk patients compared with patients with no genetic predisposition or family history. To consider conservative risk reduction measures that do not involve oophorectomy. Ethical issues In the absence of family history or genetic predisposition to ovarian or breast cancer, is it ethical to perform routine oophorectomy in perimenopausal or even postmenopausal women? Is it ethical to reduce the risk of ovarian cancer while increasing all‐cause mortality and menopause‐related morbidity? Is it ethical to offer bilateral salpingectomy as a female sterilisation procedure?

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →